Lynn Anne Bristol

Array ( [id] => 9035047 [patent_doc_number] => 20130237684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'RECONSTITUTED POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/555379 [patent_app_country] => US [patent_app_date] => 2012-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 44076 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13555379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14454257 [patent_doc_number] => 10323081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains [patent_app_type] => utility [patent_app_number] => 14/130580 [patent_app_country] => US [patent_app_date] => 2012-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 10709 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617304 [patent_doc_number] => 20130022615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'Compositions and Methods for Antibodies Targeting Complement Protein C5' [patent_app_type] => utility [patent_app_number] => 13/535612 [patent_app_country] => US [patent_app_date] => 2012-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 49614 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10103881 [patent_doc_number] => 09139655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Tumor-targeting monoclonal antibodies to FZD10 and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/494822 [patent_app_country] => US [patent_app_date] => 2012-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 19753 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406655 [patent_doc_number] => 20120238724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'MUTATED IMMUNOGLOBULIN-BINDING PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/488662 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10860 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10077350 [patent_doc_number] => 09115191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Anti-EphrinB2 antibodies and methods using same' [patent_app_type] => utility [patent_app_number] => 13/488283 [patent_app_country] => US [patent_app_date] => 2012-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 49172 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9620480 [patent_doc_number] => 08790648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Methods of treating psoriasis using IL-17 receptor A antibodies' [patent_app_type] => utility [patent_app_number] => 13/472074 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 29 [patent_no_of_words] => 81329 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406661 [patent_doc_number] => 20120238728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'MULTIVALENT ANTIBODIES AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/470189 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 44744 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9510948 [patent_doc_number] => 20140147439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/115787 [patent_app_country] => US [patent_app_date] => 2012-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24448 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090233 [patent_doc_number] => 09127046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Secretion of antibodies without signal peptides from bacteria' [patent_app_type] => utility [patent_app_number] => 13/506653 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22697 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9874704 [patent_doc_number] => 08961968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Human monoclonal antibodies against CD25' [patent_app_type] => utility [patent_app_number] => 13/465181 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29993 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 300 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370178 [patent_doc_number] => 20120219569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'USE OF AN ANTI-CD151 ANTIBODY IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/447626 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10251 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336274 [patent_doc_number] => 20120202974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'PROCESS FOR THE PURIFICATION OF FC-CONTAINING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/445962 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14783 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916980 [patent_doc_number] => 20130178605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'Hetero-Dimeric Immunoglobulins' [patent_app_type] => utility [patent_app_number] => 13/695773 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 108693 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916980 [patent_doc_number] => 20130178605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'Hetero-Dimeric Immunoglobulins' [patent_app_type] => utility [patent_app_number] => 13/695773 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 108693 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346234 [patent_doc_number] => 20150231238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'OVERCOMING RESISTANCE TO ERBB PATHWAY INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/004848 [patent_app_country] => US [patent_app_date] => 2012-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 15777 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548514 [patent_doc_number] => 09273125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Human monoclonal antibody having fat-reducing effect' [patent_app_type] => utility [patent_app_number] => 13/406191 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5856 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13406191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289341 [patent_doc_number] => 20120177666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'ANTI-TGF-BETA RECEPTOR II ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/400308 [patent_app_country] => US [patent_app_date] => 2012-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9999 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13400308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10109222 [patent_doc_number] => 09144614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells' [patent_app_type] => utility [patent_app_number] => 13/356724 [patent_app_country] => US [patent_app_date] => 2012-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 13998 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13356724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227293 [patent_doc_number] => 20120141503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Heavy Chain and Domain Antibodies' [patent_app_type] => utility [patent_app_number] => 13/355981 [patent_app_country] => US [patent_app_date] => 2012-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19983 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13355981 [rel_patent_id] =>[rel_patent_doc_number] =>)